Citigroup Inc Rallybio Corp Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Rallybio Corp stock. As of the latest transaction made, Citigroup Inc holds 9,895 shares of RLYB stock, worth $6,332. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,895

Holding current value

$6,332

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$0.32 - $0.63 $3,166 - $6,233	9,895 New	9,895 $5,000
Q4 2024 Feb 12, 2025	BUY	$0.86 - $1.2 $2,057 - $2,870	2,392 Added 4349.09%	2,447 $2,000
Q3 2024 Nov 12, 2024	SELL	$1.09 - $1.45 $22,558 - $30,009	-20,696 Reduced 99.73%	55 $0
Q2 2024 Aug 12, 2024	BUY	$1.34 - $2.98 $19,300 - $42,920	14,403 Added 226.89%	20,751 $27,000
Q1 2024 May 10, 2024	SELL	$1.25 - $2.4 $9,103 - $17,479	-7,283 Reduced 53.43%	6,348 $11,000
Q4 2023 Feb 09, 2024	BUY	$1.91 - $4.39 $25,895 - $59,519	13,558 Added 18572.6%	13,631 $32,000
Q3 2023 Nov 09, 2023	SELL	$3.37 - $6.16 $30,518 - $55,784	-9,056 Reduced 99.2%	73 $0
Q2 2023 Aug 10, 2023	BUY	$4.31 - $8.89 $39,345 - $81,156	9,129 New	9,129 $51,000
Q4 2022 Feb 09, 2023	SELL	$4.67 - $14.86 $467 - $1,486	-100 Reduced 13.33%	650 $4,000
Q3 2022 Nov 10, 2022	SELL	$7.54 - $14.56 $7,155 - $13,817	-949 Reduced 55.86%	750 $11,000
Q2 2022 Aug 10, 2022	BUY	$6.26 - $13.65 $1,934 - $4,217	309 Added 22.23%	1,699 $13,000
Q1 2022 May 12, 2022	SELL	$6.91 - $15.04 $9,777 - $21,281	-1,415 Reduced 50.45%	1,390 $10,000
Q4 2021 Feb 10, 2022	BUY	$9.3 - $19.91 $18,451 - $39,501	1,984 Added 241.66%	2,805 $27,000
Q3 2021 Nov 10, 2021	BUY	$10.83 - $23.4 $8,891 - $19,211	821 New	821 $14,000

Others Institutions Holding RLYB

# of Institutions

Shares Held

29.4M

Call Options Held

Put Options Held

Viking Global Investors LP

4.19M
Shares

$2.68 Million
0.01% of portfolio
Johnson & Johnson New Brunswick, NJ

3.64M
Shares

$2.33 Million
0.47% of portfolio
5 Am Venture Management, LLC San Francisco, CA

3.63M
Shares

$2.32 Million
1.34% of portfolio
New Leaf Venture Partners, L.L.C. New York, NY

3.3M
Shares

$2.11 Million
4.2% of portfolio
Tpg Gp A, LLC Fort Worth, TX

3.03M
Shares

$1.94 Million
0.11% of portfolio

View Full List

About Rallybio Corp

Ticker RLYB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,132,000
Market Cap $20.6M
Description
Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...

More about RLYB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account